Original Article
Role of surgery following neoadjuvant chemoradiation in patients with lymph node positive locally advanced esophageal adenocarcinoma: a national cancer database analysis
Journal of Gastrointestinal Oncology
2021;
12
(5)
:1944-1950
.
(31 October 2021)
Prognostic impact of lymph node harvest for patients with node-negative esophageal squamous cell carcinoma: a large-scale multicenter study
Journal of Gastrointestinal Oncology
2021;
12
(5)
:1951-1962
.
(31 October 2021)
Prognostic models for stage I–III esophageal cancer: a comparison between existing calculators
Journal of Gastrointestinal Oncology
2021;
12
(5)
:1963-1972
.
(31 October 2021)
The comparisons of three stapler placement methods for intrathoracic mechanistic circular stapling in Ivor Lewis minimally invasive esophagectomy
Journal of Gastrointestinal Oncology
2021;
12
(5)
:1973-1984
.
(31 October 2021)
Trichostatin A enhances radiosensitivity and radiation-induced DNA damage of esophageal cancer cells
Journal of Gastrointestinal Oncology
2021;
12
(5)
:1985-1995
.
(31 October 2021)
The expression and clinical value of tumor infiltrating dendritic cells in tumor tissues of patients with esophageal cancer
Journal of Gastrointestinal Oncology
2021;
12
(5)
:1996-2003
.
(31 October 2021)
Preliminary evaluation of postoperative radiotherapy with small T-shaped field in thoracic esophageal squamous cell carcinoma
Journal of Gastrointestinal Oncology
2021;
12
(5)
:2004-2012
.
(31 October 2021)
Comparison of efficacy and safety between pembrolizumab combined with chemotherapy and simple chemotherapy in neoadjuvant therapy for esophageal squamous cell carcinoma
Journal of Gastrointestinal Oncology
2021;
12
(5)
:2013-2021
.
(31 October 2021)
Combination of the ratio between metastatic and harvested lymph nodes and negative lymph node count as a prognostic indicator in advanced gastric cancer: a retrospective cohort study
Journal of Gastrointestinal Oncology
2021;
12
(5)
:2022-2034
.
(31 October 2021)
Apatinib plus S-1 for previously treated, advanced gastric or gastro-oesophageal junction adenocarcinoma: a phase 2, single-arm, prospective study
Journal of Gastrointestinal Oncology
2021;
12
(5)
:2035-2044
.
(31 October 2021)
Deploying an artificial intelligence-based online search tool to increase patients’ access to and understanding of solid tumor gastrointestinal clinical trials
Journal of Gastrointestinal Oncology
2021;
12
(5)
:2045-2051
.
(31 October 2021)
Clinical application of nano-carbon to improve the accuracy of lymph node staging in patients with advanced gastric cancer receiving neoadjuvant chemotherapy: a prospective randomized controlled trial
Journal of Gastrointestinal Oncology
2021;
12
(5)
:2052-2060
.
(31 October 2021)
MiR-873-5p targets THUMPD1 to inhibit gastric cancer cell behavior and chemoresistance
Journal of Gastrointestinal Oncology
2021;
12
(5)
:2061-2072
.
(31 October 2021)
Correlation between L3 skeletal muscle index and prognosis of patients with stage IV gastric cancer
Journal of Gastrointestinal Oncology
2021;
12
(5)
:2073-2081
.
(31 October 2021)
Prediction and prognostic significance of ALOX12B and PACSIN1 expression in gastric cancer by genome-wide RNA expression and methylation analysis
Journal of Gastrointestinal Oncology
2021;
12
(5)
:2082-2092
.
(31 October 2021)
Long non-coding RNA HAGLROS regulates the proliferation, migration, and apoptosis of esophageal cancer cells via the HAGLROS-miR-206-NOTCH3 axis
Journal of Gastrointestinal Oncology
2021;
12
(5)
:2093-2108
.
(31 October 2021)
Identification of potential core genes in gastric cancer using bioinformatics analysis
Journal of Gastrointestinal Oncology
2021;
12
(5)
:2109-2122
.
(31 October 2021)
Clinical values and potential pathways of miR-183-5p in gastric cancer: a study based on integrational bioinformatics analysis
Journal of Gastrointestinal Oncology
2021;
12
(5)
:2123-2131
.
(31 October 2021)
Comprehensive bioinformatics analyses identified Homeobox B9 as a potential prognostic biomarker and therapeutic target for gastric cancer
Journal of Gastrointestinal Oncology
2021;
12
(5)
:2132-2149
.
(31 October 2021)
Outcome of surgical treatment for bone metastases caused by colorectal cancer
Journal of Gastrointestinal Oncology
2021;
12
(5)
:2150-2156
.
(31 October 2021)
Six mutator-derived lncRNA signature of genome instability for predicting the clinical outcome of colon cancer
Journal of Gastrointestinal Oncology
2021;
12
(5)
:2157-2171
.
(31 October 2021)
Establishment and verification of a prognostic tumor microenvironment-based and immune-related gene signature in colon cancer
Journal of Gastrointestinal Oncology
2021;
12
(5)
:2172-2191
.
(31 October 2021)
ATG16L2 overexpression is associated with a good prognosis in colorectal cancer
Journal of Gastrointestinal Oncology
2021;
12
(5)
:2192-2202
.
(31 October 2021)
Correlation of c-MET expression with clinical characteristics and the prognosis of colorectal cancer
Journal of Gastrointestinal Oncology
2021;
12
(5)
:2203-2210
.
(31 October 2021)
Survival analysis and prognostic factors of palliative radiotherapy in patients with metastatic colorectal cancer: a propensity score analysis
Journal of Gastrointestinal Oncology
2021;
12
(5)
:2211-2222
.
(31 October 2021)
TiaochangXiaoliu decoction inhibits azomethane (AOM)/dextran sulfate sodium (DSS)-induced colorectal cancer by regulating immune response
Journal of Gastrointestinal Oncology
2021;
12
(5)
:2223-2231
.
(31 October 2021)
Comprehensive analysis of immune related lncRNAs in the tumor microenvironment of stage II–III colorectal cancer
Journal of Gastrointestinal Oncology
2021;
12
(5)
:2232-2243
.
(31 October 2021)
TCGA database analysis of the tumor mutation burden and its clinical significance in colon cancer
Journal of Gastrointestinal Oncology
2021;
12
(5)
:2244-2259
.
(31 October 2021)
Safety of biliary stent placement followed by definitive chemoradiotherapy in patients with pancreatic cancer with bile duct obstruction
Journal of Gastrointestinal Oncology
2021;
12
(5)
:2260-2267
.
(31 October 2021)
Outcomes of patients with metastatic pancreatic cancer who progress on first restaging imaging
Journal of Gastrointestinal Oncology
2021;
12
(5)
:2268-2274
.
(31 October 2021)
Intact SMAD-4 is a predictor of increased locoregional recurrence in upfront resected pancreas cancer receiving adjuvant therapy
Journal of Gastrointestinal Oncology
2021;
12
(5)
:2275-2286
.
(31 October 2021)
Construction of a competing endogenous RNA network related to the prognosis of cholangiocarcinoma and comprehensive analysis of the immunological correlation
Journal of Gastrointestinal Oncology
2021;
12
(5)
:2287-2309
.
(31 October 2021)
Prognostic and immune infiltrates for the Chromobox (CBX) protein family in human pancreatic adenocarcinoma
Journal of Gastrointestinal Oncology
2021;
12
(5)
:2310-2324
.
(31 October 2021)
ACTR3 promotes cell migration and invasion by inducing epithelial mesenchymal transition in pancreatic ductal adenocarcinoma
Journal of Gastrointestinal Oncology
2021;
12
(5)
:2325-2333
.
(31 October 2021)
Stereotactic body radiation therapy versus radiofrequency ablation for single small hepatocellular carcinoma: a propensity-score matching analysis of their impact on liver function and clinical outcomes
Journal of Gastrointestinal Oncology
2021;
12
(5)
:2334-2344
.
(31 October 2021)
Identification and validation of ferroptosis-associated gene-based on immune score as prognosis markers for hepatocellular carcinoma patients
Journal of Gastrointestinal Oncology
2021;
12
(5)
:2345-2360
.
(31 October 2021)
Identification of heterogeneous nuclear ribonucleoprotein as a candidate biomarker for diagnosis and prognosis of hepatocellular carcinoma
Journal of Gastrointestinal Oncology
2021;
12
(5)
:2361-2376
.
(31 October 2021)
Diabetes mellitus and postoperative blood glucose value help predict posthepatectomy liver failure in patients with hepatocellular carcinoma
Journal of Gastrointestinal Oncology
2021;
12
(5)
:2377-2387
.
(31 October 2021)
Hsa_circ_NOTCH3 regulates ZNF146 through sponge adsorption of miR-875-5p to promote tumorigenesis of hepatocellular carcinoma
Journal of Gastrointestinal Oncology
2021;
12
(5)
:2388-2402
.
(31 October 2021)
Diagnostic role of contrast-enhanced ultrasonography versus conventional B-mode ultrasonography in cirrhotic patients with early hepatocellular carcinoma: a retrospective study
Journal of Gastrointestinal Oncology
2021;
12
(5)
:2403-2411
.
(31 October 2021)
Prognostic impact of lymphopenia and neutrophil-lymphocyte ratio for patients with anal squamous cell carcinoma
Journal of Gastrointestinal Oncology
2021;
12
(5)
:2412-2422
.
(31 October 2021)
Molecular characterization of squamous cell carcinoma of the anal canal
Journal of Gastrointestinal Oncology
2021;
12
(5)
:2423-2437
.
(31 October 2021)
Review Article
Narrative review of the role of yttrium-90 selective internal radiation therapy in the surgical management of colorectal liver metastases
Journal of Gastrointestinal Oncology
2021;
12
(5)
:2438-2446
.
(31 October 2021)
Editorial on Surgery for Locally Advanced Pancreatic Cancer1
Locally advanced pancreatic cancer—a resectable disease?
Journal of Gastrointestinal Oncology
2021;
12
(5)
:2447-2449
.
(31 October 2021)
Review Article on Surgery for Locally Advanced Pancreatic Cancer1
Resectable, borderline, and locally advanced pancreatic cancer—“the good, the bad, and the ugly” candidates for surgery?
Journal of Gastrointestinal Oncology
2021;
12
(5)
:2450-2460
.
(31 October 2021)
Neoadjuvant treatment of localized pancreatic adenocarcinoma
Journal of Gastrointestinal Oncology
2021;
12
(5)
:2461-2474
.
(31 October 2021)
Selecting surgical candidates with locally advanced pancreatic cancer: a review for modern pancreatology
Journal of Gastrointestinal Oncology
2021;
12
(5)
:2475-2483
.
(31 October 2021)
Favorable tumor biology in locally advanced pancreatic cancer—beyond CA19-9
Journal of Gastrointestinal Oncology
2021;
12
(5)
:2484-2494
.
(31 October 2021)
Extent of venous resection during pancreatectomy—finding the balance of technical possibility and feasibility
Journal of Gastrointestinal Oncology
2021;
12
(5)
:2495-2502
.
(31 October 2021)
Surgery for locally advanced pancreatic ductal adenocarcinoma—is it only about the vessels?
Journal of Gastrointestinal Oncology
2021;
12
(5)
:2503-2511
.
(31 October 2021)
Pathology reporting of margin status in locally advanced pancreatic cancer: challenges and uncertainties
Journal of Gastrointestinal Oncology
2021;
12
(5)
:2512-2520
.
(31 October 2021)
How to select the most appropriate adjuvant treatment after neoadjuvant treatment and resection for locally advanced pancreatic cancer?
Journal of Gastrointestinal Oncology
2021;
12
(5)
:2521-2535
.
(31 October 2021)
Can local ablative techniques replace surgery for locally advanced pancreatic cancer?
Journal of Gastrointestinal Oncology
2021;
12
(5)
:2536-2546
.
(31 October 2021)
Disclosure:
1. The series “Surgery for Locally Advanced Pancreatic Cancer” was commissioned by the Editorial office, Journal of Gastrointestinal Oncology without any sponsorship or funding. Elena Rangelova served as the unpaid Guest Editor for the series.
